AJ Melet - CE0 Ronawk Inc.

04/29/23 • 21 min

Life Science Success

Send us a text

AJ Melet is the CEO of a startup biotechnology company Ronawk Inc.
Ronawk Inc’s technology involves growing cells in a tissue mimetic substrate called bio blocks.
The cells grow in 3D and form their own micro tissues, which can be used to manufacture new therapies.
Roanoke's technology has potential applications in tissue engineering and scaling the production of biological factors.
The biggest challenges Roanoke is currently facing are building a new lab and getting people to understand the new technology.
AJ Melet is inspired by people who serve others, concerned about our ability to connect in a digital world, and excited by people tackling big challenges.

Send us a text

AJ Melet is the CEO of a startup biotechnology company Ronawk Inc.
Ronawk Inc’s technology involves growing cells in a tissue mimetic substrate called bio blocks.
The cells grow in 3D and form their own micro tissues, which can be used to manufacture new therapies.
Roanoke's technology has potential applications in tissue engineering and scaling the production of biological factors.
The biggest challenges Roanoke is currently facing are building a new lab and getting people to understand the new technology.
AJ Melet is inspired by people who serve others, concerned about our ability to connect in a digital world, and excited by people tackling big challenges.

Previous Episode

Katherine Vega Stultz - President and CEO of Ocelot Bio

Send us a text

In this episode of Life Science Success, my guest is Katherine Vega Stultz. Katherine is the President and CEO of Ocelot Bio, a clinical stage company focused on developing innovative therapeutics to significantly improve outcomes for patients with end-stage liver disease.

In this episode of Life Science Success my guest is Katherine Vega Stultz and we touch upon a number of topics, including the non-linear path of career growth, the importance of being a generalist in a specialized industry, and the challenges and opportunities facing Ocelot Bio, a private venture-backed company that is focused on liver disease. Stultz talks about the importance of team collaboration, transparency, and communication, and how her experiences have helped her develop a continuous improvement mindset. She also discusses her passion for tackling complex problems that impact people's lives and how she is excited to be in a position of leadership that advocates for diversity and talent.

Non-linear path of career growth
Importance of being a generalist in a specialized industry
Challenges and opportunities facing Ocelot Bio
Importance of team collaboration, transparency, and communication
Continuous improvement mindset
Passion for tackling complex problems that impact people's lives
Advocacy for diversity and talent in leadership

Next Episode

Gino Martini PhD FrPharmS MBA - CEO PHTA

Send us a text

In this episode of Life Science Success, my guest is Gino Martini. Gino is the CEO of the Precision Health Technologies Accelerator (PHTA Ltd). Previously, he was the Chief Scientist of the Royal Pharmaceutical Society.

Key Topics Covered:

Description of an accelerator program for health tech companies
The importance of social interaction for innovation in a hybrid work environment
Excitement for precision medicine and personalized treatment plans
Interest in bedside manufacturing and its potential for patient care
Challenges in the life sciences industry, such as the lack of lab space and access to skills
Opportunities in precision medicine, bedside manufacturing, and the microbiome